Abstract

S-nitrosylation is a post-translational modification on cysteine(s) that can regulate protein function, and pannexin 1 (Panx1) channels are present in the vasculature, a tissue rich in nitric oxide (NO) species. Therefore, we investigated whether Panx1 can be S-nitrosylated and whether this modification can affect channel activity. Using the biotin switch assay, we found that application of the NO donor S-nitrosoglutathione (GSNO) or diethylammonium (Z)-1-1(N,N-diethylamino)diazen-1-ium-1,2-diolate (DEA NONOate) to human embryonic kidney (HEK) 293T cells expressing wild type (WT) Panx1 and mouse aortic endothelial cells induced Panx1 S-nitrosylation. Functionally, GSNO and DEA NONOate attenuated Panx1 currents; consistent with a role for S-nitrosylation, current inhibition was reversed by the reducing agent dithiothreitol and unaffected by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, a blocker of guanylate cyclase activity. In addition, ATP release was significantly inhibited by treatment with both NO donors. To identify which cysteine residue(s) was S-nitrosylated, we made single cysteine-to-alanine substitutions in Panx1 (Panx1(C40A), Panx1(C346A), and Panx1(C426A)). Mutation of these single cysteines did not prevent Panx1 S-nitrosylation; however, mutation of either Cys-40 or Cys-346 prevented Panx1 current inhibition and ATP release by GSNO. This observation suggested that multiple cysteines may be S-nitrosylated to regulate Panx1 channel function. Indeed, we found that mutation of both Cys-40 and Cys-346 (Panx1(C40A/C346A)) prevented Panx1 S-nitrosylation by GSNO as well as the GSNO-mediated inhibition of Panx1 current and ATP release. Taken together, these results indicate that S-nitrosylation of Panx1 at Cys-40 and Cys-346 inhibits Panx1 channel currents and ATP release.

Highlights

  • Pannexin 1 contains multiple cysteine residues and is highly expressed in cell types rich in nitric oxide species

  • Using the biotin switch assay, we found that application of the nitric oxide (NO) donor S-nitrosoglutathione (GSNO) or diethylammonium (Z)-1–1(N,N-diethylamino)diazen-1-ium1,2-diolate (DEA NONOate) to human embryonic kidney (HEK) 293T cells expressing wild type (WT) pannexin 1 (Panx1) and mouse aortic endothelial cells induced Panx1 S-nitrosylation

  • GSNO did not affect the expression of soluble guanylate cyclase (sGC), we observed a significant increase in intracellular cGMP concentration following GSNO treatment in Panx1WT-expressing HEK cells that could be blocked by pretreatment with the sGC inhibitor ODQ (Fig. 2E)

Read more

Summary

Background

Pannexin 1 contains multiple cysteine residues and is highly expressed in cell types rich in nitric oxide species. Pannexin 1 (Panx1) is a widely expressed integral membrane protein that is thought to form hexameric plasma membrane channels [1] Since their identification in 2000, Panx channels have been characterized as ATP release channels that may play a pivotal role in supporting purinergic signaling in a multitude of cell types [2,3,4,5,6,7,8,9,10,11,12,13,14]. Panx channels can be irreversibly modified during apoptosis by cleavage of the intracellular C-tail by caspases, allowing release of ATP that serves as a “find-me” signal for monocyte recruitment and phagocytosis [9, 25] Whereas recognition of these post-translational modifications has provided critical insight into the regulation of Panx trafficking and the role of Panx in apoptosis, there are currently no known reversible post-translational modifications involved in the regulation of Panx channel activity at the plasma membrane

The abbreviations used are
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call